Transplantation of dopaminergic or neurotrophic tissues is an experime
ntal treatment of Parkinson's Disease. However, in animal models susta
ined recovery may occur after surgical trauma to affected brain areas
even in the absence of grafted tissue. Consequently, brain tissue reac
ting to local trauma in these experiments must be capable of substanti
al neurotrophic responses. To evaluate the potential of astrocytes in
these neurotrophic responses, cultures were obtained from gelatin impl
ants into striatal cavities that were created in hemiparkinsonian rats
. The type 1 astrocyte phenotype as determined immunocytochemically wa
s maximal at day 7 in vitro and paralleled the glial reaction in the a
djacent brain parenchyma. Neurite-promoting activity of the culture me
dium was determined in a chick dorsal root ganglion bioassay and also
was established by 7 days. Nerve growth factor antibodies neutralized
only around 40% of this activity. Neurotrophic activity was absent wit
h assay of media from early or long-term newborn rat astrocytes, and o
f medium conditioned by a monoyte/macrophage cell line. Passage after
several months yielded astrocyte cultures that repeated a surge of neu
rite-promoting activity. This long-term potential to produce multiple
neurotrophic factors indicates that autologous astrocytes in affected
brain regions may serve either as targets for or agents of therapy of
Parkinsonism. (C) 1995 Wiley-Liss, Inc.